Viewing Study NCT04534218


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-01-26 @ 4:53 AM
Study NCT ID: NCT04534218
Status: COMPLETED
Last Update Posted: 2024-12-20
First Post: 2020-07-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2020/490
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View